Kathmandu. Sopan Pharmaceuticals Company Limited is issuing Initial Public Offering (IPO) to the general public from today.

The company has been allowed to issue 42,90,000 units of shares worth Rs 42.90 crore i.e. 25% of the issued capital of Rs 1.71 billion.

Out of this, 10 percent has already issued 429,000 units of shares for the Nepalese who are employed abroad after taking work permit. The company has already set aside 1,71,600 units for the employees of the company and 2,14,500 units for the mutual funds.

In the second phase, the company is issuing 34,74,900 units of shares worth Rs 34,74,90,000 to the general public.

Applications can be place for minimum 10 units and maximum 11,000 units. The last date to apply for the IPO is April 6.

NMB Capital has been appointed as the issue manager for the IPO issuance. The investors can apply for the shares from the Securities Board of Nepal (SEBON) through the banks and financial institutions that are members of the company.